THE SOLUTION
- Product NDC
- 82617-101
- 11-digit product format
- 826170101
- Labeler code
- 82617
- Product ID
- 82617-101_2b369998-00c4-fcb6-e063-6294a90af2eb
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- LIDOCAINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE
- Dosage form
- SPRAY
- Route
- TOPICAL
- Labeler
- SCALP TECH INC
- Application
- M015
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2022-04-01
- Substance
- LIDOCAINE HYDROCHLORIDE; EPINEPHRINE HYDROCHLORIDE
- Active strength
- 5; .01 g/100mL; g/100mL
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 82617-101-14 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 82617-101-14 | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- THE SOLUTION
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LIDOCAINE HYDROCHLORIDE | 5 g/100mL |
| EPINEPHRINE HYDROCHLORIDE | .01 g/100mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| V13007Z41A | Internal UNII lookup |
| WBB047OO38 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2601579 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| df51623c-e0b6-8e86-e053-2995a90a59b2 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 82617-101-14 | THE SOLUTION | 118 mL in 1 BOTTLE, SPRAY | SPRAY | 118 | 4 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DCH Rapid Relief Hemorrhoidal | LIDOCAINE 5%, PHENYLEPHRINE HYDROCHLORIDE 0.25% | Derma Care Research Labs | 00eef84c-a72e-3343-e063-6294a90aa4d8 | 2024-12-19 | Warnings | M015 |
| Formula 2 Skin Care | LIDOCAINE 5% | Derma Care Research Labs | a05d5e07-ae4b-38cc-e053-2a95a90abced | 2024-12-19 | Warnings | M015 |
| Revivol Hemorrhoid and Fissure | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0140cf68-b6a0-4378-e063-6394a90afee8 | 2024-12-19 | Warnings | M015 |
| Hemorroidal Cooling gel | PHENYLEPHRINE, WITCH HAZEL | Trifecta Pharmaceuticals Usa Llc | 651c0143-384c-3649-e053-2991aa0a0f28 | 2024-12-18 | Warnings | M015 |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | c50cc6ad-e8a0-47c1-e053-2a95a90a4de6 | 2024-12-18 | Warnings | M015 |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | fe18fa61-83f9-8bf9-e053-6294a90a7585 | 2024-12-18 | Warnings | M015 |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | c59dcb2a-392b-670b-e053-2995a90a9682 | 2024-12-18 | Warnings | M015 |
| TheraCare Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Veridian Healthcare | fab95657-d257-e671-e053-6294a90a59e0 | 2024-12-18 | Warnings | M015 |
| TN Dickinsons Witch Hazel Hemorrhoidal Pads | WITCH HAZEL | Dickinson Brands Inc. | 1b50f4dc-c26a-431a-ae18-c43513871b39 | 2024-12-18 | Warnings | M015 |
| RECTICARE | LIDOCAINE | Ferndale Laboratories, Inc. | 49cb48cf-7a26-4d7a-887f-2e98261d269d | 2024-12-17 | Warnings | M015 |
| Recticare Advanced | LIDOCAINE AND MINERAL OIL AND PHENYLEPHRINE HCL AND WHITE PETROLATUM | Ferndale Laboratories, Inc. | 209212a7-7b6e-4b26-9f31-0eeb76f026bf | 2024-12-17 | Warnings | M015 |
| RECTICARE | LIDOCAINE AND GLYCERIN | Ferndale Laboratories, Inc. | 2b94136a-4975-2925-e054-00144ff88e88 | 2024-12-17 | Warnings | M015 |
| PRAX | PRAMOXINE HYDROCHLORIDE | Ferndale Laboratories, Inc. | 674f0d8b-3d50-42b1-8401-d2967bcdf5cf | 2024-12-17 | Warnings | M015 |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Rugby | a5b5e0a9-eee9-2a1e-e053-2a95a90a464e | 2024-12-17 | Warnings | M015 |
| Warrior Rectal Care | LIDOCAINE 4%, PHENYLEPHRINE HYDROCHLORIDE 0.25% | Derma Care Research Labs | fc10cbc3-fc1b-ae09-e053-6394a90ac8f3 | 2024-12-15 | Warnings | M015 |
| Tucks Multi-Care Relief Kit (Tucks Hemorrhoidal and Tucks Medicated Cooling 40 Count) | GLYCERIN, LIDOCAINE, AND WITCH HAZEL | Blistex Inc | a7cb6d78-3048-43b3-afe7-4d862fdcfd3f | 2024-12-13 | Warnings | M015 |
| Tucks Medicated Cooling Pads | WITCH HAZEL | Blistex Inc | b3e68008-3d0d-4124-9579-b503e9fb95c9 | 2024-12-13 | Warnings | M015 |
| T.N. Dickinsons Witch Hazel Medicated Cooling Pads Hemorrhoidal Relief | WITCH HAZEL | Dickinson Brands Inc. | 2a4273a4-3bda-4653-a065-cd4578053f3c | 2024-12-12 | Warnings | M015 |
| Witch Hazel | WITCH HAZEL | Medical Products Laboratories, Inc. | b815792f-2f8f-7ac8-e053-2995a90ade18 | 2024-12-11 | Warnings | M015 |
| Zensa | LIDOCAINE | Alera Skin Care Products Inc. | f56146b6-3c11-4608-a6ab-6142f27e9ac3 | 2024-11-24 | Warnings | M015 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2601579 | EPINEPHrine HCl 0.01 % / lidocaine HCl 5 % Rectal Spray | PSN | df51623c-e0b6-8e86-e053-2995a90a59b2 | 4 |
| 2601579 | epinephrine hydrochloride 0.1 MG/ML / lidocaine hydrochloride 50 MG/ML Rectal Spray | SCD | df51623c-e0b6-8e86-e053-2995a90a59b2 | 4 |
| 2601579 | epinephrine hydrochloride 0.01 % / lidocaine hydrochloride 5 % Rectal Spray | SY | df51623c-e0b6-8e86-e053-2995a90a59b2 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 82617-101-14 | 82617010114 | 118 mL in 1 BOTTLE, SPRAY (82617-101-14) | 118 ml | 2022-04-01 | 0000-00-00 | No | No | Current |